+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019

  • PDF Icon

    Report

  • 78 Pages
  • December 2019
  • Region: Global
  • GlobalData
  • ID: 4898085
Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019“ provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Optical Coherence Tomography (OCT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Introduction
1.1 Optical Coherence Tomography (OCT) Overview
2 Products under Development
2.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
2.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory
2.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
2.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
2.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
3 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies
3.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
4 Optical Coherence Tomography (OCT) Companies and Product Overview
4.1 Canon USA Inc Company Overview
4.1.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
4.2 Carl Zeiss Meditec AG Company Overview
4.2.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
4.3 Compact Imaging Inc. Company Overview
4.3.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.4 Conavi Medical Inc. Company Overview
4.4.1 Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
4.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
4.6 Duke University Company Overview
4.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
4.7 George Washington University Company Overview
4.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview
4.8 Haag-Streit AG Company Overview
4.8.1 Haag-Streit AG Pipeline Products & Ongoing Clinical Trials Overview
4.9 Heidelberg Engineering GmbH Company Overview
4.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.10 Leica Microsystems GmbH Company Overview
4.10.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.11 Moorfields Eye Hospital NHS Foundation Trust Company Overview
4.11.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
4.12 Nippon Telegraph and Telephone Corp Company Overview
4.12.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
4.13 Notal Vision Inc Company Overview
4.13.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
4.14 OptoQuest Company Overview
4.14.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview
4.15 Optos Plc Company Overview
4.15.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
4.16 Optovue Inc Company Overview
4.16.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
4.17 Rowiak GmbH Company Overview
4.17.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
4.18 Sinoora Inc. Company Overview
4.18.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.19 University of California Berkeley Company Overview
4.19.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
4.20 University of Illinois at Chicago Company Overview
4.20.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
4.21 University of Liverpool Company Overview
4.21.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview
4.22 University of Pittsburgh Company Overview
4.22.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
4.23 University of Rochester Company Overview
4.23.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
4.24 University of Texas at Austin Company Overview
4.24.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
5 Optical Coherence Tomography (OCT)- Recent Developments
5.1 Oct 12, 2019: ZEISS showcases next-level eye care digitalization at AAO 2019
5.2 Oct 09, 2019: Canon U.S.A. to showcase eyecare solutions At American Academy of Ophthalmology 2019 Meeting
5.3 Oct 09, 2019: Topcon to attend American Academy of Ophthalmology 2019 Meeting
5.4 Sep 17, 2019: Canon Xephilio OCT-A1 Optical Coherence Tomography Device receives FDA 510(k) clearance
5.5 Sep 16, 2019: Ping an energizes Smart Healthcare with technology, Healthcare Ecosystem to be a future highlight
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
Table 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
Table 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
Table 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
Table 6: Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
Table 7: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table 8: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: SPOCT HR - Product Status
Table 10: SPOCT HR - Product Description
Table 11: Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ZEISS CIRRUS 6000 - Product Status
Table 13: ZEISS CIRRUS 6000 - Product Description
Table 14: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: MRO Optical Imaging Sensor - Product Status
Table 16: MRO Optical Imaging Sensor - Product Description
Table 17: Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Novasight Hybrid System - Product Status
Table 19: Novasight Hybrid System - Product Description
Table 20: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 21: MD-SD-OCT Instrument - Product Status
Table 22: MD-SD-OCT Instrument - Product Description
Table 23: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 24: HH - SDOCT - Product Status
Table 25: HH - SDOCT - Product Description
Table 26: Microscope Integrated OCT System - Product Status
Table 27: Microscope Integrated OCT System - Product Description
Table 28: Whole Eye Optical Coherence Tomography Scanner - Product Status
Table 29: Whole Eye Optical Coherence Tomography Scanner - Product Description
Table 30: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Amplified Bimorph Scanning Mirror System - Product Status
Table 32: Amplified Bimorph Scanning Mirror System - Product Description
Table 33: Haag-Streit AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: EYESTAR 900 - Product Status
Table 35: EYESTAR 900 - Product Description
Table 36: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Cataract And Refractive Imaging Device - Product Status
Table 38: Cataract And Refractive Imaging Device - Product Description
Table 39: SPECTRALIS OCT2 Module - OCT Angiography - Product Status
Table 40: SPECTRALIS OCT2 Module - OCT Angiography - Product Description
Table 41: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 42: DI-SDOCT Imaging System - Product Status
Table 43: DI-SDOCT Imaging System - Product Description
Table 44: SDOCT Scanner - Product Status
Table 45: SDOCT Scanner - Product Description
Table 46: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Binocular Optical Coherence Tomography - Product Status
Table 48: Binocular Optical Coherence Tomography - Product Description
Table 49: Moorfields Eye Hospital NHS Foundation Trust - Ongoing Clinical Trials Overview
Table 50: Binocular Optical Coherence Tomography - The Future of Cataract Assessment: Investigation of the Utility of a Novel Binocular OCT System for Clinical Application
Table 51: Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 52: High - Speed Wavelength Swept Light - Based OCT Device - Product Status
Table 53: High - Speed Wavelength Swept Light - Based OCT Device - Product Description
Table 54: Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Notal Home OCT System - Product Status
Table 56: Notal Home OCT System - Product Description
Table 57: Notal Vision Inc - Ongoing Clinical Trials Overview
Table 58: Notal Home OCT System - Comparison Between Retinal Images Captured by NOTAL-OCT V2.5 and Zeiss Cirrus / Heidelberg Spectralis SD OCT - Study Protocol
Table 59: Notal Home OCT System - Patient-operated Home OCT Device for Monitoring Patients Diagnosed with Exudative Age-related Macular Degeneration (eAMD): First US Clinical Trial
Table 60: Notal Home OCT System - Retinal Imaging Using NOTAL-OCT
Table 61: Notal Home OCT System - Retinal Imaging Using NOTAL-OCT V2.
Table 62: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Vectralis - Product Status
Table 64: Vectralis - Product Description
Table 65: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Falcon I - Product Status
Table 67: Falcon I - Product Description
Table 68: Falcon II - Product Status
Table 69: Falcon II - Product Description
Table 70: Lotte - Product Status
Table 71: Lotte - Product Description
Table 72: Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Intelligent OCT Retinal Disease Screening System - Product Status
Table 74: Intelligent OCT Retinal Disease Screening System - Product Description
List of Figures
Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Figure 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
Figure 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
Figure 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
Figure 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Canon USA Inc
  • Carl Zeiss Meditec AG
  • Compact Imaging Inc.
  • Conavi Medical Inc.
  • Costruzioni Strumenti Oftalmici Cso Srl
  • Duke University
  • George Washington University
  • Haag-Streit AG
  • Heidelberg Engineering GmbH
  • Leica Microsystems GmbH
  • Moorfields Eye Hospital NHS Foundation Trust
  • Nippon Telegraph and Telephone Corp
  • Notal Vision Inc
  • OptoQuest
  • Optos Plc
  • Optovue Inc
  • Rowiak GmbH
  • Sinoora Inc.
  • University of California Berkeley
  • University of Illinois at Chicago
  • University of Liverpool
  • University of Pittsburgh
  • University of Rochester
  • University of Texas at Austin